Global Companion Animal Vaccine Market by Product Type (Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine), Animal Type (Canine, Equine, Feline), Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Companion Animal Vaccine Market by Product Type (Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine), Animal Type (Canine, Equine, Feline), Distribution Channel - Forecast 2024-2030

Report
189 Pages
March 2024
Region: Global
360iResearch™
ID: 5674687

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Companion Animal Vaccine Market size was estimated at USD 4.61 billion in 2023, USD 4.97 billion in 2024, and is expected to grow at a CAGR of 8.18% to reach USD 8.01 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Companion Animal Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Companion Animal Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Vaccine Market, highlighting leading vendors and their innovative profiles. These include Biogénesis Bagó, Biovet Private Ltd., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health, Hester Biosciences Limited, Hipra Laboratories, S.A., ImmuCell Corporation, Merck & Co., Neogen Corporation, Novartis AG, Ourofino Animal Health, Phibro Animal Health Corporation, Sanofi S.A., and Virbac Group.

Market Segmentation & Coverage

This research report categorizes the Companion Animal Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Attenuated Live Vaccine
- Conjugate Vaccine
- DNA Vaccine
- Inactivated Vaccine
- Recombinant Vaccine
- Subunit Vaccine
- Toxoid Vaccine
Animal Type
- Canine
- Equine
- Feline
Distribution Channel
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Companion Animal Vaccine Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Companion Animal Vaccine Market?
What are the technology trends and regulatory frameworks in the Companion Animal Vaccine Market?
What is the market share of the leading vendors in the Companion Animal Vaccine Market?
Which modes and strategic moves are suitable for entering the Companion Animal Vaccine Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Companion Animal Vaccine Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of companion animals worldwide
5.1.1.2. Growing prevalence of companion animal disorders
5.1.1.3. Rising consumer expenditure for animal health and welfare
5.1.2. Restraints
5.1.2.1. High costs of vaccines and unfavorable governmental frameworks
5.1.3. Opportunities
5.1.3.1. Ongoing vaccination drives and organizational efforts for animal welfare
5.1.3.2. Availability of pet insurance and penetration of pet insurance service providers
5.1.4. Challenges
5.1.4.1. Adverse impacts of animal vaccination
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Companion Animal Vaccine Market, by Product Type

6.1. Introduction
6.2. Attenuated Live Vaccine
6.3. Conjugate Vaccine
6.4. DNA Vaccine
6.5. Inactivated Vaccine
6.6. Recombinant Vaccine
6.7. Subunit Vaccine
6.8. Toxoid Vaccine

7. Companion Animal Vaccine Market, by Animal Type

7.1. Introduction
7.2. Canine
7.3. Equine
7.4. Feline

8. Companion Animal Vaccine Market, by Distribution Channel

8.1. Introduction
8.2. Veterinary Clinics
8.3. Veterinary Hospitals
8.4. Veterinary Research Institutes

9. Americas Companion Animal Vaccine Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Companion Animal Vaccine Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Companion Animal Vaccine Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Biogénesis Bagó
13.1.2. Biovet Private Ltd.
13.1.3. Boehringer Ingelheim International GmbH
13.1.4. Ceva Santé Animale
13.1.5. Elanco Animal Health
13.1.6. Hester Biosciences Limited
13.1.7. Hipra Laboratories, S.A.
13.1.8. ImmuCell Corporation
13.1.9. Merck & Co.
13.1.10. Neogen Corporation
13.1.11. Novartis AG
13.1.12. Ourofino Animal Health
13.1.13. Phibro Animal Health Corporation
13.1.14. Sanofi S.A.
13.1.15. Virbac Group
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. COMPANION ANIMAL VACCINE MARKET RESEARCH PROCESS
FIGURE 2. COMPANION ANIMAL VACCINE MARKET SIZE, 2023 VS 2030
FIGURE 3. COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COMPANION ANIMAL VACCINE MARKET DYNAMICS
FIGURE 7. COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 10. COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. COMPANION ANIMAL VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 6. COMPANION ANIMAL VACCINE MARKET SIZE, BY ATTENUATED LIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. COMPANION ANIMAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. COMPANION ANIMAL VACCINE MARKET SIZE, BY DNA VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. COMPANION ANIMAL VACCINE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. COMPANION ANIMAL VACCINE MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 14. COMPANION ANIMAL VACCINE MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. COMPANION ANIMAL VACCINE MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. COMPANION ANIMAL VACCINE MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. COMPANION ANIMAL VACCINE MARKET LICENSE & PRICING

Companies Mentioned

Biogénesis Bagó
Biovet Private Ltd.
Boehringer Ingelheim International GmbH
Ceva Santé Animale
Elanco Animal Health
Hester Biosciences Limited
Hipra Laboratories, S.A.
ImmuCell Corporation
Merck & Co.
Neogen Corporation
Novartis AG
Ourofino Animal Health
Phibro Animal Health Corporation
Sanofi S.A.
Virbac Group

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 4.97 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.01 Billion
Compound Annual Growth Rate	8.1%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Veterinary/Animal Vaccines Market by Type (Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine), Disease (Aquaculture, Companion Animal, Livestock), Technology - Forecast 2024-2030

Companion Animal Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts- 2023 to 2031

Global Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Forecast 2024-2030

Companion Animal Veterinary Vaccines Global Market Report 2024

Companion Animal Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

About the Companion Animal Vaccine Market